Codexis
Presence
Codexis is one of the...
Codexis is a company listed under the stock ticker CDXS (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Codexis
Popular executive movements at Codexis
- Jennifer Aaker, Director, will leave the company in Jun. 2024 (posted on February 19 2024).
Create your alert
to follow the executive moves at Codexis.
Biotechnology
Codexis has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Codexis
- Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
- Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
- Codexis Reports First Quarter 2023 Financial Results
- Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA
- Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency
- Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
- Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™
- Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
- Codexis Announces Appointment of H. Stewart Parker to Board of Directors
- Codexis Reports Third Quarter 2022 Financial Results
- View more press releases Close
Social media about Codexis
- Codexis on Wikipedia, Google News & Yahoo Finance
- Codexis on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Stephen Dilly 
